1. Home
  2. ONDS vs OGN Comparison

ONDS vs OGN Comparison

Compare ONDS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ondas Holdings Inc.

ONDS

Ondas Holdings Inc.

HOLD

Current Price

$6.22

Market Cap

3.6B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.76

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ONDS
OGN
Founded
2014
1923
Country
United States
United States
Employees
495
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ONDS
OGN
Price
$6.22
$13.76
Analyst Decision
Strong Buy
Hold
Analyst Count
10
5
Target Price
★ $18.88
$11.25
AVG Volume (30 Days)
★ 46.1M
2.0M
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ N/A
N/A
EPS
0.38
★ 0.95
Revenue
$50,731,000.00
★ $6,216,000,000.00
Revenue This Year
$957.99
N/A
Revenue Next Year
$88.66
$2.51
P/E Ratio
$15.95
★ $14.48
Revenue Growth
★ 605.31
N/A
52 Week Low
$4.95
$5.69
52 Week High
$15.28
$13.83

Technical Indicators

Market Signals
Indicator
ONDS
OGN
Relative Strength Index (RSI) 37.94 54.03
Support Level $6.22 $13.46
Resistance Level $7.98 $13.77
Average True Range (ATR) 0.39 0.04
MACD -0.03 -0.00
Stochastic Oscillator 23.41 34.78

Price Performance

Historical Comparison
ONDS
OGN

About ONDS Ondas Holdings Inc.

Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: